MD, PhD Magnus Löndahl one of 4 principal investigators of the large randomized controlled trial of LeucoPatch/3C Patch on diabetic foot ulcers presented “Clinical experiences with LeucoPatch and status of the large RCT: Leucopatch™ System in the Management of Hard-To-Heal Diabetic Foot Ulcers” at the 4th annual Innovations in Wound Healing meeting December 9th 2017 in Bimini, Bahamas. In addition, PostDoc Jonas Schmidt was selected to present data supporting the proposed mode of action. Interest among the mainly US clinicians was high and they were pleased to hear that all patients have been finalized and the database closed for analysis. Just like the Reapplix team, they too are eagerly awaiting publication of the results in 2018.